These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 15044850)
1. Use of methotrexate-based peptide substrates to characterize the substrate specificity of prostate-specific membrane antigen (PSMA). Mhaka A; Gady AM; Rosen DM; Lo KM; Gillies SD; Denmeade SR Cancer Biol Ther; 2004 Jun; 3(6):551-8. PubMed ID: 15044850 [TBL] [Abstract][Full Text] [Related]
2. Targeting prostate-specific membrane antigen in cancer therapy: can molecular medicine be brought to the surface? Leach F Cancer Biol Ther; 2004 Jun; 3(6):559-60. PubMed ID: 15153802 [TBL] [Abstract][Full Text] [Related]
4. A dimeric peptide that binds selectively to prostate-specific membrane antigen and inhibits its enzymatic activity. Aggarwal S; Singh P; Topaloglu O; Isaacs JT; Denmeade SR Cancer Res; 2006 Sep; 66(18):9171-7. PubMed ID: 16982760 [TBL] [Abstract][Full Text] [Related]
5. PSMA-targeted stably linked "dendrimer-glutamate urea-methotrexate" as a prostate cancer therapeutic. Huang B; Otis J; Joice M; Kotlyar A; Thomas TP Biomacromolecules; 2014 Mar; 15(3):915-23. PubMed ID: 24392665 [TBL] [Abstract][Full Text] [Related]
6. Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells. Pinto JT; Suffoletto BP; Berzin TM; Qiao CH; Lin S; Tong WP; May F; Mukherjee B; Heston WD Clin Cancer Res; 1996 Sep; 2(9):1445-51. PubMed ID: 9816319 [TBL] [Abstract][Full Text] [Related]
7. Expression of prostate-specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non-polyglutamated folate, folic acid. Yao V; Berkman CE; Choi JK; O'Keefe DS; Bacich DJ Prostate; 2010 Feb; 70(3):305-16. PubMed ID: 19830782 [TBL] [Abstract][Full Text] [Related]
8. [Advances in prostate-specific membrane antigen-mediated antitumor drugs]. Lü QZ; Yang JC; Wang YJ Yao Xue Xue Bao; 2016 Feb; 51(2):234-40. PubMed ID: 29856576 [TBL] [Abstract][Full Text] [Related]
9. PSMA-Oriented Target Delivery of Novel Anticancer Prodrugs: Design, Synthesis, and Biological Evaluations of Oligopeptide-Camptothecin Conjugates. Xu B; Zhou F; Yan MM; Cai DS; Guo WB; Yang YQ; Jia XH; Zhang WX; Li T; Ma T; Wang PL; Lei HM Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347770 [TBL] [Abstract][Full Text] [Related]
10. In vitro targeted killing of prostate tumor cells by a synthetic amoebapore helix 3 peptide modified with two gamma-linked glutamate residues at the COOH terminus. Warren P; Li L; Song W; Holle E; Wei Y; Wagner T; Yu X Cancer Res; 2001 Sep; 61(18):6783-7. PubMed ID: 11559551 [TBL] [Abstract][Full Text] [Related]
11. A ROS-responsive polymeric prodrug nanosystem with self-amplified drug release for PSMA (-) prostate cancer specific therapy. Wang Y; Zhang Y; Ru Z; Song W; Chen L; Ma H; Sun L J Nanobiotechnology; 2019 Aug; 17(1):91. PubMed ID: 31451114 [TBL] [Abstract][Full Text] [Related]
13. Disulfide-constrained peptides that bind to the extracellular portion of the prostate-specific membrane antigen. Lupold SE; Rodriguez R Mol Cancer Ther; 2004 May; 3(5):597-603. PubMed ID: 15141017 [TBL] [Abstract][Full Text] [Related]
14. Impact of short-term Dutasteride treatment on prostate-specific membrane antigen expression in a mouse xenograft model. Kranzbühler B; Sousa R; Prause L; Burger IA; Rupp NJ; Sulser T; Salemi S; Eberli D Cancer Rep (Hoboken); 2021 Dec; 4(6):e1418. PubMed ID: 34008909 [TBL] [Abstract][Full Text] [Related]
15. Glycoforms of human prostate-specific membrane antigen (PSMA) in human cells and prostate tissue. Yuan W; Liu B; Sanda M; Wei R; Benicky J; Novakova Z; Barinka C; Goldman R Prostate; 2022 Jan; 82(1):132-144. PubMed ID: 34662441 [TBL] [Abstract][Full Text] [Related]
16. Effect of carbohydrate moieties on the folate hydrolysis activity of the prostate specific membrane antigen. Ghosh A; Heston WD Prostate; 2003 Oct; 57(2):140-51. PubMed ID: 12949938 [TBL] [Abstract][Full Text] [Related]
17. Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancer. Liu C; Hasegawa K; Russell SJ; Sadelain M; Peng KW Prostate; 2009 Jul; 69(10):1128-41. PubMed ID: 19367568 [TBL] [Abstract][Full Text] [Related]
18. GCPII imaging and cancer. Foss CA; Mease RC; Cho SY; Kim HJ; Pomper MG Curr Med Chem; 2012; 19(9):1346-59. PubMed ID: 22304713 [TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of canine prostate-specific membrane antigen. Schmidt S; Fracasso G; Colombatti M; Naim HY Prostate; 2013 May; 73(6):642-50. PubMed ID: 23359458 [TBL] [Abstract][Full Text] [Related]
20. New alternatively spliced variant of prostate-specific membrane antigen PSM-E suppresses the proliferation, migration and invasiveness of prostate cancer cells. Cao KY; Xu L; Zhang DM; Zhang XM; Zhang T; He X; Wang Z; Feng FS; Qiu SP; Shen GX Int J Oncol; 2012 Jun; 40(6):1977-85. PubMed ID: 22322627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]